Nectar Lifesciences (NSE:NECLIFE) EV-to-EBITDA : 6.61 (As of May. 29, 2025)

Nectar Lifesciences EV-to-EBITDA Chart

Nectar Lifesciences Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
EV-to-EBITDA		Get a 7-Day Free Trial					5.15	21.14	8.58	10.97	7.65

Nectar Lifesciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EV-to-EBITDA	Get a 7-Day Free Trial															4.64	7.65	4.06	8.37	4.80

Competitive Comparison of Nectar Lifesciences's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Nectar Lifesciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nectar Lifesciences's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nectar Lifesciences's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Nectar Lifesciences's EV-to-EBITDA falls into.

Nectar Lifesciences EV-to-EBITDA Calculation

Nectar Lifesciences's EV-to-EBITDA for today is calculated as:

Nectar Lifesciences's current Enterprise Value is ₹12,034 Mil.
Nectar Lifesciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,821 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nectar Lifesciences  (NSE:NECLIFE) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Nectar Lifesciences's PE Ratio (TTM) for today is calculated as:

Nectar Lifesciences's share price for today is ₹26.75.
Nectar Lifesciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.750.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Nectar Lifesciences EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Nectar Lifesciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Nectar Lifesciences Business Description